Billable / Specific Code
ICD-10-CM D3A.091 is the diagnosis code for Benign carcinoid tumor of the thymus. This code falls under the section "Benign neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where D3A.091 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, D3A.091 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
D3A.091 is the ICD-10-CM diagnosis code for "Benign carcinoid tumor of the thymus". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of D3A.091 is D3A.09 ("Benign carcinoid tumors of other sites"). D3A.091 provides a more specific classification within this category.
D3A.091 is located in Section D3A — "Benign neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
Use D3A.091 when the patients documented diagnosis matches "Benign carcinoid tumor of the thymus" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Benign carcinoid tumor of the thymus is D3A.091.
Yes, D3A.091 can be used as a primary diagnosis code since it is billable and specific.
D3A.091 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, D3A.091 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.